As the use of GLP‐1 agonists like Semaglutide becomes increasingly popular for managing obesity, the aesthetic consequences of rapid weight loss are becoming more apparent. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.